New hope for bedsores: 2,000-Patient trial tests advanced wound matrices

NCT ID NCT07665268

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding special wound dressings (called CAMPs) to standard care helps heal pressure ulcers (bedsores) that won't close on their own. About 2,000 adults with stage 3 or 4 pressure sores will receive weekly applications of a CAMP product plus standard care, or standard care alone, for up to 20 weeks. The main goal is to see if more ulcers close completely with the added treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Cellular, acellular, and matrix-like products (CAMPs) such as Activate™ Matrix, AmnioDefend™ FT Matrix, and Palisade™ DM Matrix
What this could lead to
If successful, this could provide a new treatment option to help heal stubborn pressure ulcers faster and more completely.
What could go wrong
This is a large trial, but results may vary by product and patient. Some ulcers may not heal, and there is a risk of infection or side effects from the products.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC ULCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Amber Stormer

    RECRUITING

    North Royalton, Ohio, 44133, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.